Author

J. A. Johnston

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

A. Budelsky· 1 shared A. Hochheimer· 1 shared A. Leith· 1 shared B. Bennett· 1 shared B. Coder· 1 shared B. Liu· 1 shared B. Vander Lugt· 1 shared C. Mottershead· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

A. Budelsky

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Listeria monocytogenes personalized cancer vaccines drive therapeutic immune responses to cancer derived neoantigens

B. Coder, O. Pryshchep, D. Kelkar, E. Filippova, X. Ju, D. Balli, C. Mottershead, K. Ramos, N. Thambi, Z. Cheng, B. Vander Lugt, J. Lesch, X. Liu, J. DeVoss, K. Cooke, , M. Princiotta

This study demonstrates that ADXS-NEO, a personalized Listeria monocytogenes vaccine, effectively targets tumor-specific mutations and controls tumor growth in mice by inducing neoantigen-specific T cell responses.

bioRxiv · May 11, 2020 · PreprintImmunology

Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide are Potent TMEM16A Antagonists that Fully Bronchodilate Airways

K. Miner, K. Labitzke, B. Liu, P. Wang, K. Henckels, K. Gaida, R. Elliott, J. J. Chen, L. Liu, A. Leith, E. Trueblood, K. Hensley, X.-Z. Xia, O. Homann, B. Bennett, , J. K. Sullivan

This paper identifies niclosamide and nitazoxanide as potent TMEM16A antagonists that fully bronchodilate airways, offering new treatment options for severe asthma and COPD.

bioRxiv · Nov 14, 2018Physiology